Show simple item record

Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)

dc.contributor.authorOnal, Sumru
dc.contributor.authorTugal-Tutkun, Ilknur
dc.date.accessioned2021-03-03T10:54:21Z
dc.date.available2021-03-03T10:54:21Z
dc.date.issued2014
dc.identifier.citationOnal S., Tugal-Tutkun I., "Re: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)", OPHTHALMOLOGY, cilt.121, sa.10, 2014
dc.identifier.issn0161-6420
dc.identifier.othervv_1032021
dc.identifier.otherav_253b7d5e-e9e6-4f51-a4de-305285f19a17
dc.identifier.urihttp://hdl.handle.net/20.500.12627/29918
dc.identifier.urihttps://doi.org/10.1016/j.ophtha.2014.05.033
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectCerrahi Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectOFTALMOLOJİ
dc.titleRe: Levy-Clarke et al.: Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders (Ophthalmology 2014;121:785-96)
dc.typeMakale
dc.relation.journalOPHTHALMOLOGY
dc.contributor.departmentKoç Üniversitesi , ,
dc.identifier.volume121
dc.identifier.issue10
dc.contributor.firstauthorID25051


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record